Introduction Implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death due to ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). The ...
The recent analysis by Quadintel on the global Thrombectomy Devices Market Report 2022 revolves around various aspects of the market, including characteristics, size and growth, segmentation, regional ...
MIAMI--(BUSINESS WIRE)--Rehab Boost, a pioneer in artificial intelligence (AI) body motion recognition technology, today announced that its Board of Directors names Jennifer Browning Holmes as Chief ...
Philips is moving one of its Fremont manufacturing operations to Minnesota and cutting 80 local jobs
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The electronics giant is closing one of the two medical ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LAS VEGAS — New data from the ILLUMENATE EU randomized ...
September 14, 2017—Royal Philips announced the 2-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating the efficacy of Philips Spectranetics' Stellarex 0.035-inch ...
AMSTERDAM and LAS VEGAS, Sept. 11, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its presence at the Vascular Interventional Advances ...
Royal Philips subsidiary Spectranetics recalled its Bridge occlusion balloon after receiving reports of blocked guidewire lumens. The Bridge device is used to temporarily block the superior vena cava ...
The FINANCIAL — Royal Philips on August 9 announced that it has completed the acquisition of The Spectranetics Corporation, a U.S.-based one of the global leaders in vascular intervention and lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results